FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386416797> ?p ?o ?g. }

• W4386416797 abstract "Abstract Gonadotropin-releasing hormone agonist (GnRHa) appears to exhibit ovarian protection during chemotherapy for malignant tumors. The purpose of this study was to analyze the benefits of GnRHa in premenopausal women undergoing hematopoietic cell transplantation (HSCT). Candidates for myeloablative chemotherapy HSCT requiring fertility preservation in the Gynecological Endocrinology Clinic of Peking University People’s Hospital from December 2011 to December 2021 were retrospectively analyzed. Patients who chose to receive GnRHa treatment were given at least 2 courses of a 3.75-mg dose of a GnRHa before myeloablative chemotherapy, and patients who chose not to receive GnRHa treatment were included in the control group. All patients were monitored for menstruation return and menopause-related symptoms, and ovarian function tests [follicle-stimulating hormone (FSH), luteinizing hormone, and estradiol] were performed 6–12 months after HSCT. In addition, we assessed the vaginal bleeding of patients in the laminar air-flow room (LAFR). A total of 234 cases were included in this study: 77 cases in the treatment group and 157 cases in the control group. The incidence of vaginal bleeding in the LAFR in the treatment group was significantly lower than that in the control group (24.68% vs. 79.62%, P < 0.001). The menopausal symptoms of the patients in the treatment group were reduced after transplantation (46.75% vs. 19.75%, P < 0.001). There was no difference in visible follicles by follow-up ultrasound in the two groups after HSCT (16.88% vs. 13.38%, P = 0.474). The level of FSH at 6–12 months after transplantation was lower (98.00 mIU/ml vs. 117.53 mIU/ml, P = 0.001). The proportion of patients with FSH < 40 mIU/ml did not differ between the two groups. One patient in the treatment group recovered spontaneous menstruation, while none recovered spontaneous menstruation in the control group (1.30% vs. 0%, P = 0.329). The use of GnRHa may relieve menopause-related symptoms and reduce vaginal bleeding in the LAFR and breakthrough bleeding after transplantation. GnRHa treatment can reduce the level of FSH after myeloablative chemotherapy, but it cannot reduce the incidence of premature ovarian failure in women of reproductive age following myeloablative HSCT." @default.
• W4386416797 created "2023-09-05" @default.
• W4386416797 creator A5013487786 @default.
• W4386416797 creator A5043774051 @default.
• W4386416797 creator A5048956289 @default.
• W4386416797 creator A5054247393 @default.
• W4386416797 creator A5070174401 @default.
• W4386416797 creator A5074969670 @default.
• W4386416797 date "2023-09-04" @default.
• W4386416797 modified "2023-10-16" @default.
• W4386416797 title "Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation" @default.
• W4386416797 cites W1651399846 @default.
• W4386416797 cites W1955291661 @default.
• W4386416797 cites W1974765254 @default.
• W4386416797 cites W1995238507 @default.
• W4386416797 cites W2014034979 @default.
• W4386416797 cites W2031942208 @default.
• W4386416797 cites W2036203498 @default.
• W4386416797 cites W2039602589 @default.
• W4386416797 cites W2052226853 @default.
• W4386416797 cites W2053062054 @default.
• W4386416797 cites W2063500255 @default.
• W4386416797 cites W2117878780 @default.
• W4386416797 cites W2123533470 @default.
• W4386416797 cites W2123656462 @default.
• W4386416797 cites W2132639855 @default.
• W4386416797 cites W2140450399 @default.
• W4386416797 cites W2141047141 @default.
• W4386416797 cites W2172218197 @default.
• W4386416797 cites W2323013979 @default.
• W4386416797 cites W2789496953 @default.
• W4386416797 cites W2795588819 @default.
• W4386416797 cites W2806870447 @default.
• W4386416797 cites W2969215191 @default.
• W4386416797 cites W3038173071 @default.
• W4386416797 cites W3076504843 @default.
• W4386416797 cites W4200403864 @default.
• W4386416797 cites W4296094503 @default.
• W4386416797 doi "https://doi.org/10.1038/s41598-023-40778-2" @default.
• W4386416797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37666835" @default.
• W4386416797 hasPublicationYear "2023" @default.
• W4386416797 type Work @default.
• W4386416797 citedByCount "0" @default.
• W4386416797 crossrefType "journal-article" @default.
• W4386416797 hasAuthorship W4386416797A5013487786 @default.
• W4386416797 hasAuthorship W4386416797A5043774051 @default.
• W4386416797 hasAuthorship W4386416797A5048956289 @default.
• W4386416797 hasAuthorship W4386416797A5054247393 @default.
• W4386416797 hasAuthorship W4386416797A5070174401 @default.
• W4386416797 hasAuthorship W4386416797A5074969670 @default.
• W4386416797 hasBestOaLocation W43864167971 @default.
• W4386416797 hasConcept C121608353 @default.
• W4386416797 hasConcept C126322002 @default.
• W4386416797 hasConcept C2776694085 @default.
• W4386416797 hasConcept C2777408962 @default.
• W4386416797 hasConcept C2778043895 @default.
• W4386416797 hasConcept C2778562196 @default.
• W4386416797 hasConcept C2778575703 @default.
• W4386416797 hasConcept C2779279165 @default.
• W4386416797 hasConcept C2911091166 @default.
• W4386416797 hasConcept C29456083 @default.
• W4386416797 hasConcept C530470458 @default.
• W4386416797 hasConcept C71315377 @default.
• W4386416797 hasConcept C71924100 @default.
• W4386416797 hasConceptScore W4386416797C121608353 @default.
• W4386416797 hasConceptScore W4386416797C126322002 @default.
• W4386416797 hasConceptScore W4386416797C2776694085 @default.
• W4386416797 hasConceptScore W4386416797C2777408962 @default.
• W4386416797 hasConceptScore W4386416797C2778043895 @default.
• W4386416797 hasConceptScore W4386416797C2778562196 @default.
• W4386416797 hasConceptScore W4386416797C2778575703 @default.
• W4386416797 hasConceptScore W4386416797C2779279165 @default.
• W4386416797 hasConceptScore W4386416797C2911091166 @default.
• W4386416797 hasConceptScore W4386416797C29456083 @default.
• W4386416797 hasConceptScore W4386416797C530470458 @default.
• W4386416797 hasConceptScore W4386416797C71315377 @default.
• W4386416797 hasConceptScore W4386416797C71924100 @default.
• W4386416797 hasIssue "1" @default.
• W4386416797 hasLocation W43864167971 @default.
• W4386416797 hasLocation W43864167972 @default.
• W4386416797 hasOpenAccess W4386416797 @default.
• W4386416797 hasPrimaryLocation W43864167971 @default.
• W4386416797 hasRelatedWork W1991634850 @default.
• W4386416797 hasRelatedWork W2053271595 @default.
• W4386416797 hasRelatedWork W2064034534 @default.
• W4386416797 hasRelatedWork W2067589401 @default.
• W4386416797 hasRelatedWork W2073502422 @default.
• W4386416797 hasRelatedWork W2089937133 @default.
• W4386416797 hasRelatedWork W2091556654 @default.
• W4386416797 hasRelatedWork W2397441112 @default.
• W4386416797 hasRelatedWork W3047871921 @default.
• W4386416797 hasRelatedWork W3217017441 @default.
• W4386416797 hasVolume "13" @default.
• W4386416797 isParatext "false" @default.
• W4386416797 isRetracted "false" @default.
• W4386416797 workType "article" @default.